Open Positions
The available positions for the 1st (spring) call are listed below. They may be subject to changes until the closing of the call.
The positions for the 2nd (summer) call are not yet available. They will be published on this page once the call opens.
The description will soon be available for all the positions listed below, you can anyway check the info on the lab opening the position by clicking the link on the name of the PI.
|
Surname & Name
|
Research center/University
|
Research Areas
|
N. of positions
|
Title of the project
|
Description
|
|---|---|---|---|---|---|
|
the AIRC Institute of Molecular Oncology (IFOM)
|
Cancer Biology, Molecular and Cellular Biology
|
1
|
Identifying Functional Proteomic Signatures in
Epithelioid Sarcoma
|
||
|
Human Technopole (HT)
|
Cancer Biology, Computational Biology, Molecular and Cellular Biology
|
2
|
1) De novo discovery from RNA to Protein in patient-derived cancer models (experimental);
2) De novo discovery from RNA to Protein in patient-derived cancer models (computational)
|
||
|
European Institute of Oncology (IEO)
|
Cancer Biology, Molecular and Cellular Biology
|
1
|
A systems-level approach to unravel the crosstalk between tumor microenvironment and ovarian cancer stem cells
|
||
|
the AIRC Institute of Molecular Oncology (IFOM)
|
Computational Biology
|
1
|
Decoding the splicing code of KRAS G12C inhibitor resistance in lung adenocarcinoma
|
||
|
the AIRC Institute of Molecular Oncology (IFOM)
|
Cancer Biology, Molecular and Cellular Biology, Structural Biology
|
2
|
1) Synthetic Lethality Approaches to selectively kill BRCA1 and BRCA2 Deficient Tumors by targeting DNA replication gaps; 2) How DNA Repair Proteins Integrate Multiple DNA Metabolism Pathways to Safeguard Genome Stability
|
||
|
the AIRC Institute of Molecular Oncology (IFOM)
|
Cancer Biology, Molecular and Cellular Biology
|
1
|
How do tumor cells accumulate extrachromosomal circular DNA?
|
||
|
National Institute of Molecular Genetics (INGM)
|
Immunology, Cancer Biology
|
1
|
Conditioning the gut ecosystem to enhance immune checkpoint
blockade efficacy via enterotropic T cells
|
||
|
European Institute of Oncology (IEO)
|
Molecular and Cellular Biology
|
1
|
Setting up a photocatalytic proximity labeling platform for high-specificity detection of dynamic molecular interactions in the transcriptional machinery
|
||
|
the AIRC Institute of Molecular Oncology (IFOM)
|
Cancer Biology, Immunology, Molecular and Cellular Biology
|
2
|
1) Functional dissection of cerebral cavernous malformations epigenetic drivers using single-cell CRISPR screens; 2) Novel hypoxia-based regulatory T cell programs in tumor-immune communication
|
||
|
European Institute of Oncology (IEO)
|
Cancer Biology, Genomic Medicine, Molecular and Cellular Biology
|
1
|
Genomic rearrangements at epithelial-gene enhancers as drivers of mesenchymal transition and metastatization in breast cancer: mechanisms of occurrence and transcriptional de-regulation
|
|
|
|
European Institute of Oncology (IEO)
|
Medical Humanities
|
2
|
1) Digital approaches to psychological screening in oncology; 2) Psychological Wellbeing and Artificial Intelligence across cancer trajectory
|
||
|
European Institute of Oncology (IEO)
|
Cancer Biology
|
1
|
Metabolic Vulnerabilities and Adaptations in Aneuploid Cancers
|
||
|
European Institute of Oncology (IEO)
|
Cancer Biology, Molecular and Cellular Biology
|
3
|
Epigenetic mechanisms in health and cancer
|
||
|
European Institute of Oncology (IEO)
|
Cancer Biology, Computational Biology, Genomic Medicine
|
1
|
Modelling immunotherapy response in cancer
|
||
|
the AIRC Institute of Molecular Oncology (IFOM)
|
Cancer Biology, Computational Biology
|
2
|
Translational spatial profiling
|
||
|
University of Trento
|
Computational Biology
|
1
|
Microbiome signatures of early on-set colorectal cancer
|
||
|
Human Technopole (HT)
|
Computational Biology, Immunology
|
2
|
1) Dissecting B cell fate decisions: integrating omics and imaging to reveal drivers of plasma cell differentiation; 2) Genetic and regulatory determinants of altered B cell function in immune diseases
|
||
|
European Institute of Oncology (IEO)
|
Computational Biology
|
2
|
RNAseq-Driven Machine Learning framework for Predicting Immunotherapy Response
|
||
|
Various PIs at TIGEM
|
Telethon Institute of Genetics and Medicine (TIGEM)
|
Genomic Medicine, Molecular and Cellular Biology, Molecular Therapy
|
3
|
The "More info" file contains the project details for each research area
|